Epidemiological data [ 1 , 2 ] indicate a global prevalence of 150–250 cases per million, with an annual incidence rate of 1.7–30 per million, showing an increasing trend over the years.
← all excerpts
Mitochondrial dysfunction in myasthenia gravis: Exploring directions for future immunotherapy? A review.
1
—
—